Cell Impact AB (CI) — Cash Flow Reinvestment Rate
Latest as of September 2024:
4.72x
Cell Impact AB (CI) has a Cash Flow Reinvestment Rate of 4.72x as of September 2024, reinvesting Skr4.00 Million (capex Skr2.00 Million plus investments Skr-2.00 Million) from operating cash flow of Skr847.00K. Explore CI capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
4.72x
(Capex + Investments) / Operating CF
Total Reinvested
Skr4.00 Million
Capex + Investments
Operating Cash Flow
Skr847.00K
SEK
Capital Expenditures
Skr2.00 Million
SEK
Annual Cash Flow Reinvestment Rate for Cell Impact AB (None–None)
Year-by-year capital reinvestment analysis for Cell Impact AB. For live market cap and broader valuation context, see market value of Cell Impact AB.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow